BWM
EBS icon

Baron Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Baron Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
16,239
+1,119
+7% +$9.36K 0.04% 299
2026
Q1 		$125K Buy
15,120
+4,335
+40% +$44.9K 0.04% 275
2025
Q4 		$133K Buy
+10,785
New +$116K 0.04% 246

Other funds holding EBS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MFT
Moisand Fitzgerald Tamayo Orlando, Florida $1.02B AUM 21.26% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Baron Wealth Management's EBS Position: Q2 2026 in Review

Baron Wealth Management increased its Emergent Biosolutions (EBS) stake by 7.4% in Q2 2026, buying an estimated $9.36K and bringing the position to 16,239 shares worth $136K. The position accounts for 0.04% of the portfolio, ranked #299.

Baron Wealth Management first reported a position in EBS in Q4 2025 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Baron Wealth Management held 16,239 shares of Emergent Biosolutions worth $136K as of Q2 2026.
  • Baron Wealth Management bought 1,119 Emergent Biosolutions shares in Q2 2026, an estimated $9.36K.
  • Emergent Biosolutions made up 0.04% of Baron Wealth Management's portfolio in Q2 2026, its #299 holding.
  • Baron Wealth Management first reported a position in Emergent Biosolutions in Q4 2025 and has held it in 3 quarters since.
  • 17 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Baron Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.